Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: Apr 04, 2022

Reversal Agents in Sedation and Anesthesia Practice for Dentistry

DDS, MSc, EdD
Page Range: 49 – 58
DOI: 10.2344/anpr-69-01-09
Save
Download PDF

Reversal agents are defined as any drug used to counteract the pharmacologic effects of another drug. Several pharmacologic antagonists serve as essential drugs in the contemporary practices of sedation providers and anesthesiologists. Reversal or “antidote” drugs, such as flumazenil and naloxone, are often used in unintentional overdose situations involving significant benzodiazepine- and/or opioid-induced respiratory depression. Within the context of skeletal muscle relaxation, neostigmine and sugammadex are routinely used to reverse the effects of nondepolarizing neuromuscular blocking agents. In addition, the alpha-adrenergic antagonist phentolamine is used in dentistry as a local anesthetic reversal agent, decreasing its duration of action by inducing vasodilation. This review article discusses the pharmacology, uses, practical implications, adverse effects, and precautions needed for flumazenil, naloxone, neostigmine, sugammadex, and phentolamine within the context of sedation and anesthesia practice for dentistry.

  • Download PDF
<bold>Figure 1. </bold>
Figure 1. 

Schematic of GABAA receptor depicting competitive antagonism between flumazenil and midazolam at the benzodiazepine (BZD) binding site. Flumazenil acts as a negative allosteric modulator of GABA by facilitating closure of the chloride ion (Cl) channel and preventing the influx of Cl ions.


<bold>Figure 2. </bold>
Figure 2. 

Molecular structure of sugammadex.


Contributor Notes

Address correspondence to Dr Michelle Wong, 124 Edward Street, Suite 256 (M5G 1G6), Toronto, Ontario, Canada.
Received: Dec 29, 2021
Accepted: Feb 02, 2022